查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866351

临床实验供应与物流市场－2025-2030年预测

Clinical Trial Supply and Logistics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床实验供应和物流市场预计将从 2025 年的 53.1 亿美元成长到 2030 年的 75.38 亿美元，复合年增长率为 7.26%。

由于对先进药物研发的需求不断增长以及疾病复杂性的日益增加，全球临床实验供应和物流市场预计将迎来强劲成长。临床实验对于评估药物安全性至关重要，需要专业的设备和后勤支援以确保结果的准确性。该市场的服务供应商在研究方法中发挥关键作用，他们提供必要的资源、管理试验场地并促进患者互动。疾病盛行率的上升和对创新治疗方法的需求是推动市场成长的主要因素，但高昂的初始成本和对熟练劳动力的需求构成了准入壁垒，加剧了现有企业之间的激烈竞争。

市场驱动因素

医药研发投资快速成长

对药物研发投入的不断成长是临床实验供应和物流市场的主要驱动力。製药公司和创业投资正将大量资金投入临床实验，以应对日益复杂的疾病及其不断增加的发病率。研发活动的激增需要可靠的供应链来提供高品质的设备和材料，这直接推动了市场需求。全球药物研发计划的扩张凸显了高效物流的重要性，以确保按时、按量、按质地交付物资，从而确保试验顺利进行。专注于开发应对新兴健康挑战的新药，将在预测期内进一步提升市场成长前景。

缺乏替代方案巩固了市场地位

由于缺乏可行的替代方案，供应商在临床实验供应物流市场的地位更加稳固。儘管一些製药公司可能会考虑自行管理供应链，但确保及时、高品质交货的高成本和风险阻​​碍了这些努力。出于降低成本和规避风险的考虑，药物研发企业越来越依赖能够提供临床实验所需专业知识和基础设施的专业物流供应商。这种缺乏替代方案的现状赋予了供应商强大的市场力量，使他们能够保持竞争优势，并充分利用日益增长的外包物流解决方案需求。

区域展望

北美和欧洲市场预计将主导全球临床实验供应和物流行业，这主要得益于这些地区医药研究机构的高度集中。先进的基础设施、完善的法规结构以及大量的研发投入，为市场成长创造了有利环境。同时，亚太地区预计将受益于不断增长的医药研究活动和不断完善的医疗基础设施而快速扩张。该地区的成长也得益于不断增加的投资和有利的政策，并正逐步成为全球市场的重要贡献者。

市场展望

受药物研发投入不断增加和缺乏替代解决方案的推动，临床实验供应和物流市场预计到2030年将显着扩张。北美和欧洲凭藉其强大的医药生态系统将继续保持主导地位，而亚太地区将成为高成长市场。儘管面临准入门槛高、劳动力技能要求高等挑战，但竞争激烈的市场格局及其在药物研发中的关键作用确保了其强劲的成长前景。相关人员需要专注于创新和扩充性，以满足全球临床研究不断变化的需求。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 全球临床实验供应与物流市场（依服务类型划分）

  • 介绍
  • 製造业
  • 包装/展示
  • 贮存
  • 其他的

6. 全球临床实验供应与物流市场（依临床实验阶段划分）

  • 介绍
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

7. 全球临床实验供应与物流市场（按应用划分）

  • 介绍
  • 瘤
  • 心臟病
  • 呼吸系统疾病
  • 中枢神经系统和精神疾病
  • 其他的

8. 全球临床实验供应和物流市场（按最终用户划分）

  • 介绍
  • 製药和生物技术公司
  • CRO（委外研发机构）
  • 其他的

9. 全球临床实验供应与物流市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十一章 公司简介

  • DHL International GmbH
  • Marken
  • Parexel International Corporation
  • Movianto
  • Catalent Inc.
  • Thermo Fisher Scientific Inc.
  • Almac Group
  • FedEx
  • PCI Pharma Service
  • Sharp Services, LLC

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061611181

The Clinical Trial Supply And Logistics Market is expected to increase from USD 5.310 billion in 2025 to USD 7.538 billion in 2030, with a 7.26% CAGR.

The global clinical trial supply and logistics market is set to experience robust growth, driven by the escalating demand for advanced drug development and the increasing complexity of diseases. Clinical trials, critical for assessing drug safety, require specialized equipment and logistics support to ensure accurate outcomes. Service providers in this market supply essential resources, manage trial sites, and facilitate patient interactions, playing a pivotal role in the research process. The market is propelled by rising disease prevalence and the need for innovative treatments, though high initial costs and the need for a skilled workforce pose barriers to new entrants, fostering intense competition among established players.

Market Drivers

Surge in Drug Research Investments

The increasing investment in drug research is a primary driver of the clinical trial supply and logistics market. Pharmaceutical companies and venture capitalists are funding clinical trials to address the growing complexity and incidence of diseases. This surge in research activities necessitates reliable supply chains for high-quality equipment and materials, directly boosting market demand. The expansion of drug development projects globally underscores the need for efficient logistics to deliver supplies in the right quantity, quality, and timeframe, ensuring seamless trial execution. The focus on developing novel drugs to combat emerging health challenges further amplifies the market's growth prospects during the forecast period.

Lack of Substitutes Enhances Market Position

The absence of viable substitutes strengthens the position of vendors in the clinical trial supply and logistics market. While some pharmaceutical companies may consider managing supply chains in-house, the high costs and risks associated with ensuring timely and quality-compliant deliveries deter such efforts. The emphasis on cost reduction and risk mitigation has driven drug developers to rely on specialized logistics providers, who offer expertise and infrastructure tailored to clinical trial needs. This lack of alternatives grants suppliers significant market power, enabling them to maintain a competitive edge and capitalize on the growing demand for outsourced logistics solutions.

Geographical Outlook

The North American and European markets are expected to dominate the global clinical trial supply and logistics industry, primarily due to the high concentration of pharmaceutical research organizations in these regions. Their advanced infrastructure, regulatory frameworks, and significant R&D investments create a conducive environment for market growth. Meanwhile, the Asia Pacific region is projected to experience rapid expansion, driven by increasing pharmaceutical research activities and improving healthcare infrastructure. The region's growth is further supported by rising investments and favorable policies, positioning it as a key contributor to the global market.

Market Outlook

The clinical trial supply and logistics market is poised for significant expansion through 2030, fueled by heightened drug research investments and the absence of substitute solutions. North America and Europe will lead due to their robust pharmaceutical ecosystems, while the Asia Pacific region emerges as a high-growth market. Despite challenges like high entry barriers and workforce skill requirements, the market's competitive landscape and critical role in drug development ensure strong growth prospects. Stakeholders must focus on innovation and scalability to meet the evolving demands of global clinical research.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Service Type

  • Manufacturing
  • Packaging & Labeling
  • Storing
  • Others

By Clinical Phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Application

  • Oncology
  • Cardiology
  • Respiratory Disease
  • CNS & Mental Disorders
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY SERVICE TYPE

  • 5.1. Introduction
  • 5.2. Manufacturing
  • 5.3. Packaging & Labeling
  • 5.4. Storing
  • 5.5. Others

6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY CLINICAL PHASE

  • 6.1. Introduction
  • 6.2. Phase 1
  • 6.3. Phase 2
  • 6.4. Phase 3
  • 6.5. Phase 4

7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Cardiology
  • 7.4. Respiratory Disease
  • 7.5. CNS & Mental Disorders
  • 7.6. Others

8. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Contract Research Organization (CRO)
  • 8.4. Others

9. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. DHL International GmbH
  • 11.2. Marken
  • 11.3. Parexel International Corporation
  • 11.4. Movianto
  • 11.5. Catalent Inc.
  • 11.6. Thermo Fisher Scientific Inc.
  • 11.7. Almac Group
  • 11.8. FedEx
  • 11.9. PCI Pharma Service
  • 11.10. Sharp Services, LLC

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations